TY - BOOK AU - Olson,Steve AU - Claiborne,Anne B. ED - Institute of Medicine (U.S.). ED - National Institute of Medicine (U.S.). TI - Maximizing the impact of the Cures Acceleration Network: accelerating the development of new drugs and diagnostics : workshop summary AV - RM302 .I58 2012 U1 - 615.1/9 23 PY - 2012///] CY - Washington, District of Columbia PB - National Academies Press KW - United States KW - Institutes of Health KW - National Center for Advancing Translational Sciences KW - Cures Acceleration Network KW - Drug monitoring KW - Drug development KW - Drugs KW - Design KW - Pharmaceutical industry KW - Quality control KW - Electronic books N1 - Includes bibliographical references (pages 71); Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN N2 - Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description UR - https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3379066 ER -